HUTCHMED (China) Limited
HCM · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $139 | $139 | $162 | $162 |
| % Growth | 0% | -14.4% | 0% | – |
| Cost of Goods Sold | $84 | $84 | $190 | $190 |
| Gross Profit | $55 | $55 | -$28 | -$28 |
| % Margin | 39.7% | 39.7% | -17.4% | -17.4% |
| R&D Expenses | $36 | $36 | $59 | $59 |
| G&A Expenses | $14 | $14 | $32 | $32 |
| SG&A Expenses | $21 | $21 | $28 | $28 |
| Sales & Mktg Exp. | $7 | $7 | $24 | $24 |
| Other Operating Expenses | $0 | $0 | -$107 | -$107 |
| Operating Expenses | $57 | $57 | -$20 | -$20 |
| Operating Income | -$2 | -$2 | -$8 | -$8 |
| % Margin | -1.3% | -1.3% | -5% | -5% |
| Other Income/Exp. Net | $261 | $261 | $16 | $16 |
| Pre-Tax Income | $259 | $259 | $8 | $8 |
| Tax Expense | $32 | $32 | $2 | $2 |
| Net Income | $227 | $227 | $6 | $6 |
| % Margin | 163.8% | 163.8% | 3.7% | 3.7% |
| EPS | 1.35 | 1.35 | 0.035 | 0.035 |
| % Growth | 0% | 3,757.1% | 0% | – |
| EPS Diluted | 1.3 | 1.3 | 0.025 | 0.025 |
| Weighted Avg Shares Out | 175 | 175 | 238 | 238 |
| Weighted Avg Shares Out Dil | 175 | 175 | 175 | 175 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $19 | $19 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $3 | $3 | $3 | $3 |
| EBITDA | $1 | $1 | -$5 | -$5 |
| % Margin | 0.9% | 0.9% | -3.1% | -3.1% |